REBECCA HASH: Open Payments
NPI 1306250550 · MURRELLS INLET, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,961 in 90 payments from 18 companies in 2025. Trend: 2023 $1,247 · 2024 $944 · 2025 $1,961
Food & beverage: $1,861Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $350 |
| Janssen Biotech, Inc. | 10 | $293 |
| QOL Medical, LLC | 9 | $236 |
| Ardelyx, Inc. | 10 | $221 |
| Madrigal Pharmaceuticals | 7 | $162 |
| Intercept Pharmaceuticals, Inc. | 6 | $154 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $64 |
| Braintree Laboratories, Inc. | 3 | $59 |
| Gilead Sciences, Inc. | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
Products named: TREMFYA, Sucraid, IBSRELA, REZDIFFRA, OCALIVA, RINVOQ, CREON, SKYRIZI.
Industry payments across SC — which companies pay providers there.
